In this study, we investigated the efficacy of combining [177Lu]Lu-DOTAGA.(SA.FAPi)2 and CXCR4 antagonist AMD3100 against the 4T1 murine breast tumor model. The gene discussed is CXCR4; the disease is breast neoplasm.